Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pons

Showing results (351-360 of 394) with videos related to

Pageof 40
Sort By:
Arthritis Care & Research|April 19, 2018
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and RepositoryOzan Unlu, Doruk Erkan, Medha Barbhaiya, et al.
Lupus Science & Medicine|March 18, 2026
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trialsKathryn Connelly, Eric Morand, Rachel Koelmeyer, et al.
Annals of the Rheumatic Diseases|September 24, 2017
Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)Manuel Francisco Ugarte-Gil, Daniel Wojdyla, Guillermo J Pons-Estel, et al.
Seminars in Arthritis and Rheumatism|March 15, 2017
Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohortVictor R Pimentel-Quiroz, Manuel F Ugarte-Gil, Guillermo J Pons-Estel, et al.
Rheumatology International|November 5, 2021
Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin AmericaDaniel G Fernández-Ávila, Julián Barahona-Correa, Diana Romero-Alvernia, et al.
The Journal of Rheumatology|July 30, 2021
Impact of COVID-19 Pandemic on Rheumatology Practice in Latin AmericaDaniel G Fernández-Ávila, Julián Barahona-Correa, Diana Romero-Alvernia, et al.
Lupus|July 17, 2013
Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohortG J Pons-Estel, G S Alarcón, P I Burgos, et al.
Annals of the Rheumatic Diseases|November 22, 2025
Development and validation of a EULAR disease activity score in antiphospholipid syndromeMaria G Tektonidou, Ricard Cervera, Angela Tincani, et al.
The Journal of Rheumatology|March 3, 2019
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American CohortManuel F Ugarte-Gil, Daniel Wojdyla, Guillermo J Pons-Estel, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 23, 2025
Adverse Effects Related to SARS-CoV-2 Vaccination in Patients With Rheumatic Diseases and Psoriasis From ArgentinaCarolina A Isnardi, Cecilia Pisoni, Micaela Cosatti, et al.
Pageof 40

Showing results (351-360 of 394) with videos related to

Sort By:
Pageof 40
Arthritis Care & Research|April 19, 2018
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and RepositoryOzan Unlu, Doruk Erkan, Medha Barbhaiya, et al.
Lupus Science & Medicine|March 18, 2026
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trialsKathryn Connelly, Eric Morand, Rachel Koelmeyer, et al.
Annals of the Rheumatic Diseases|September 24, 2017
Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL)Manuel Francisco Ugarte-Gil, Daniel Wojdyla, Guillermo J Pons-Estel, et al.
Seminars in Arthritis and Rheumatism|March 15, 2017
Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohortVictor R Pimentel-Quiroz, Manuel F Ugarte-Gil, Guillermo J Pons-Estel, et al.
Rheumatology International|November 5, 2021
Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin AmericaDaniel G Fernández-Ávila, Julián Barahona-Correa, Diana Romero-Alvernia, et al.
The Journal of Rheumatology|July 30, 2021
Impact of COVID-19 Pandemic on Rheumatology Practice in Latin AmericaDaniel G Fernández-Ávila, Julián Barahona-Correa, Diana Romero-Alvernia, et al.
Lupus|July 17, 2013
Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohortG J Pons-Estel, G S Alarcón, P I Burgos, et al.
Annals of the Rheumatic Diseases|November 22, 2025
Development and validation of a EULAR disease activity score in antiphospholipid syndromeMaria G Tektonidou, Ricard Cervera, Angela Tincani, et al.
The Journal of Rheumatology|March 3, 2019
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American CohortManuel F Ugarte-Gil, Daniel Wojdyla, Guillermo J Pons-Estel, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 23, 2025
Adverse Effects Related to SARS-CoV-2 Vaccination in Patients With Rheumatic Diseases and Psoriasis From ArgentinaCarolina A Isnardi, Cecilia Pisoni, Micaela Cosatti, et al.
Pageof 40